Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 December 2019 | Story Nonsindiso Qwabe | Photo Barend Nagel
Victoria Read more
Victoria the mannequin has become a familiar face in Nursing classrooms

She has an uncanny ability to move her eyes towards the sound of voices in a room, her voice shrills and squeals when she's in pain, she throws in a Spanish word or two, and she releases bodily fluids just like a real human would. 

These are just some of the quirky characteristics that make up the new R1,76 million-rand birthing mannequin in the School of Nursing's Simulation Unit, who goes by the name Victoria. She weighs more than 80 kg and is almost 1,7 metres high. With features such as real eyelashes, eyebrows, and hair, you can't help but do a double take when you lay eyes on her. 

Students getting practical experience

While the unit has other mannequins used for training Nursing students in each year or their study, Simulation Coordinator from the School of Nursing in the Faculty of Health Sciences, Cecile Fourie, said Victoria was a major upgrade for the school because of her versatility. Victoria would further enhance the school's quality of teaching by training students in their final year of undergraduate studies as well as those pursuing their postgraduate studies, about the ins and outs of pregnancy and other female morbidities, Fourie said. 

"We try to make our scenarios as real and authentic as possible and we've seen how much our students have grown. Introducing Victoria to our pre- and postgraduate students will prepare them to be competent in clinical practice." 

Meet Victoria

So, what exactly can Victoria do? 

Fourie said while the other mannequins were made with screws that made them look robot-like, Victoria was made with silicone and given a clean finish to make her appear life-like. The other mannequins can only blink, but Victoria's eyes move around, she can speak Spanish and French, and she comes with five tummies for different medical scenarios. She has a normal tummy which acts as a closure, an operable tummy for caesarean delivery, a tummy that allows a breeched baby to be twisted and turned from the outside just before delivery, a contraction tummy used for normal vaginal delivery – which also allows Victoria to push, bleed, urinate, and release mineral oil which acts as amniotic fluid. The fifth tummy is postpartum haemorrhage, a condition that is common among South African mothers after delivery. 

"It’s so good that we get to train our students in such real, lifelike circumstances. Through Victoria we're going to try and do our part in lessening maternal deaths, which are so prominent in our country. She can act out all the abnormalities that take place in a real delivery, and she can also have other medical conditions such as a heart attack," Fourie said.



News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept